Long-term investors are not holding for these results. They are...

First 28 Last

Share
Profile

Follow
Subs

4,845 Posts.

1558

27/07/20

10:43

Post #: 46085849
Share

Originally posted by Brett M H ↑

@ madamswer - agree with this 100%.

The business is investing in staff / R & D etc for growth & for the future - but the market cap is probably pretty fair for the current level of growth / cash flow position / profitability.

It was a good result to get to cash flow positive this quarter, but total outgoings have increased from $5,558k in the same quarter last year - to $7,381k in this quarter.

Same quarter last year generated a $566k CFP number (versus $252k this year).

And April to June appears to be a pretty strong historical quarter for cash receipts.

Therefore the business needs to significantly grow it's cash receipts / revenues going forward - to maintain a cash flow positive position, and to then (hopefully) get to profitability.

I also agree with one of the other comments - the reporting structure could do with some work IMO.

Understand that all companies want to highlight what they perceive as positives, but % comparisons versus the PCP & versus the previous quarter would assist all investors to understand the result better IMO.

Will continue to hold, and see how the next 6 to 12 months play out - and hopefully they can crank up further sales & gain even more traction in their target markets (whilst maintaining strong control over their margins / expenses / total outgoings).

Expand

Long-term investors are not holding for these results. They are holding for the massive potential that NSW Health and the UK's NHS are bringing to the table.

ALC Price at posting: 15.3¢ Sentiment: Buy Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

LU7

Strong PFS numbers solidify Lithium Universe's big plans for Québec

IRE

Iress runs 'hot' for Wealth Within's stock tips

Failure to report prompts ASX to impose multiple company suspensions

There are more pages in this discussion • 72 more messages in this thread...

First 28 Last

Add ALC (ASX) to my watchlist

(20min delay)
Last 6.0¢		Change -0.002(3.23%)		Mkt cap ! $80.57M

Open	High	Low	Value	Volume
6.2¢	6.2¢	5.7¢	$106.8K	1.801M

Buyers (Bids)

No.	Vol.	Price($)
5	387415	5.6¢

Sellers (Offers)

Price($)	Vol.	No.
6.0¢	99999	1

View Market Depth

No.	Vol.	Price($)
5	387415	0.056
3	941209	0.055
6	259426	0.054
5	268532	0.053
1	200000	0.052

Price($)	Vol.	No.
0.060	99999	1
0.062	195947	2
0.063	165254	3
0.064	43238	1
0.065	56156	2

Last trade - 16.10pm 01/10/2024 (20 minute delay)

ALC (ASX) Chart

Long-term investors are not holding for these results. They are...

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Strong PFS numbers solidify Lithium Universe's big plans for Québec

Iress runs 'hot' for Wealth Within's stock tips

Failure to report prompts ASX to impose multiple company suspensions

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Long-term investors are not holding for these results. They are...

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Strong PFS numbers solidify Lithium Universe's big plans for Québec

Iress runs 'hot' for Wealth Within's stock tips

Failure to report prompts ASX to impose multiple company suspensions

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News